ReviewInnovations in clinical neuroscience
Genetic Disorders That Confer Risk for the Development of Psychosis and White Matter Hyperintensities on T2-weighted Imaging: A Practical Guide for Psychiatrists.
Review in Innovations in clinical neuroscience. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveA variety of diseases can cause both psychosis and myelin changes that manifest as white matter hyperintensities on T2-weighted magnetic resonance imaging of the brain. Although many of the acquired conditions relevant to this discussion are widely recognized by psychiatrists and other physicians, a number of lesser-known rare genetic disorders also deserve consideration in this context. As such, this review sought to summarize the phenotypic features, brain imaging abnormalities, and approach to diagnosing the most common leukodystrophies and other genetic leukoencephalopathies that can cause psychosis.
methodsThis is a narrative review. The most common leukodystrophies that can cause both psychosis and white matter hyperintensities are first reviewed, followed by a variety of other rarer leukodystrophies and related genetic disorders. Suggestive clinical features, workup recommendations, and potential clinical implications are subsequently discussed.
resultsAlthough the psychotic symptoms that occur in these disorders might phenomenologically resemble those typical of schizophrenia, the identification of any "red flag" neurological features, idiosyncratic medical comorbidities, additional brain imaging abnormalities, parental consanguinity, or a mendelian pattern of inheritance, should prompt consideration for an underlying genetic explanation. Making a correct diagnosis in this context is critical, given the numerous potential clinical implications, including with respect to treatment decisions.
conclusionWhile psychiatrists are not expected to be experts in this area, at a minimum they should have a basic familiarity with the genetic disorders that are most likely to cause both psychosis and white matter hyperintensities, given the relatively frequent occurrence of this clinical scenario.
Indexed as
Identifiers
41647063PMC12872053What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.